A new study led by Columbia University researchers projects a substantial rise in uterine cancer incidence and deaths in the ...

Polycystic Ovary Syndrome is rising among Indian women, especially in urban areas. This article explores its symptoms, ...

Key risk factors include delayed childbearing and declining fertility rates, limited access to regular gynecological care and ...

A transvaginal ultrasound, although intrusive, is preferred for accuracy. This involves the insertion of a wand-like instrument into the vagina, which can be uncomfortable, especially for those ...

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S ®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL ...

Scientists from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, have developed a novel ultrasound-driven therapy that activates dormant cancer drugs directly inside tumors.

Endometrial cancer is the second most common gynecologic cancer and the sixth most common cancer among women globally. In 2022, ~420,000 cases were diagnosed, which led to ~97,000 deaths worldwide.

GSK and Merck & Co have both reported new clinical data with the PD-1 checkpoint inhibitors, seeking an edge in the first-line treatment of advanced endometrial cancer. Results of GSK’s RUBY ...

The surgical management of endometrial cancer has been markedly changed by minimally invasive techniques. After three decades of laparoscopy, robotic surgery has built upon and expanded the ...

GSK views the endometrial cancer indication as a catalyst to grow annual sales of Jemperli above the £1 billion ($1.27 billion) threshold, its target for the drug, which was acquired as part of ...